Non-squamous non-small cell lung cancer patients whose cancer has been tested to be PD-L1 positive (a kind of tumor marker) sought for study comparing two usual approaches to treatment.
Patients with non-squamous non-small cell lung cancer that has spread outside their lungs are usually treated with either immunotherapy drugs or a combination of immunotherapy and chemotherapy drugs. We are comparing these two different treatments for PD-L1 positive non-squamous non-small cell lung cancer to see if one of these two usual approaches is better or worse than the other.
What we're hoping for
We hope to understand how best to treat PD-L1 positive non-squamous non-small cell lung cancer in patients whose cancer has spread outside their lungs.
ClinicalTrials.gov Identifier: NCT03793179